²é¿´: 1908  |  »Ø¸´: 17
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

Ìì±ßµÄÒ»Æ¬ÔÆ

ľ³æ (ÕýʽдÊÖ)

[½»Á÷] ºËËá¼¼ÊõÏà¹Ø×ÊÔ´ÓëÎÊÌâÌÖÂÛ,Çë°ßÖñÖö¥,

ºËËá¼¼ÊõÏà¹Ø×ÊÔ´ÓëÎÊÌâÌÖÂÛ,Çë°ßÖñÖö¥,
ÎÒÔڻظ´ÌùÖн«ÉÏ´«PCR,DNA,RNA,RNAiµÈÏà¹ØÊé¼®
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÄÄÐж¼²»ºÃ¸É°¡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

miRNA

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

Ë®ÍõÖ®Íõ£¨ÓÞÓÞѧ԰¹ÜÀíÔ±£©

1

ÕªÒª£ºÎ¢Ð¡RNA»ùÒòºÍСµÄ¸ÉÉæRNAÊÇСRNAµÄ×îÖ÷Òª×é³É²¿·Ö£¬ËüÃǵÄÏà¹ØÐÔÃÜÇУ¬¼È¾ßÓÐÏàËÆÐÔ£¬ÓÖ¾ßÓвîÒìÐÔ¡£ËüÃǹ¦ÄܵÄÖØÒªÐÔÌáʾÎÒÃÇ»ùÒò×é·Çµ°°×±àÂëÇøµÄÐòÁÐÔ̺¬×ż«ÎªÖØÒªµÄÐÅÏ¢¡£¶ÔСRNAµÄÉîÈëÑо¿½«Ê¹ÎÒÃǸüÉîÒ»²½Á˽âÉúÃüµÄ°ÂÃØ¡£
¹Ø¼ü´Ê£ºÐ¡RNA£¬siRNA£¬miRNA£¬·Çµ°°×±àÂëÇø
ÒýÑÔ
³¤¶È´óСΪ¶þÊ®¼¸¸öºËÜÕËáµÄСƬ¶ÎRNAÔÚ½üÄêµÃµ½Á˼«´óµÄ¹Ø×¢£¬ÕâЩСRNAÖÐÓÐЩ¿ÉÖ±½Óµ÷¿ØÄ³Ð©»ùÒò±í´ï£¬½ø¶øµ÷¿ØÏ¸°û·¢Óý¡¢¾ö¶¨Ï¸°û·Ö»¯£¬ÓÐЩ½éµ¼ÌØÒìÐÔ·´Ó¦¡£2003Äê5Ô£¬Steven BuckinghamÌá³öµÄ±»¹ã·ºÈÏͬµÄ·ÖÀà·½·¨ÖУ¬Ð¡RNA£¨small RNAs£©ÊÇÖ¸·Ç±àÂëRNAÖгýת¼RNA£¨°üº¬ºËÌÇÌåRNAºÍ×ªÒÆRNA£©ÍâµÄ²¿·Ö£¬°üÀ¨Î¢Ð¡RNA£¨Micro RNAs£©¡¢Ð¡µÄ¸ÉÉæRNA£¨short interference RNAs £¬siRNA£©¡¢ºËÈÊС·Ö×ÓRNAºÍºËСRNA£¨snRNA£©¡£»ùÓÚ×îеĿÆÑгɹû£¬±¾ÎĶÔСRNAÓÈÆäÊÇsiRNAºÍmiRNAµÄÌØµã¡¢¹¦ÄÜ¡¢Éú³É¹ý³ÌÒÔ¼°É¸Ñ¡Ê¶±ðµÈ½øÐÐ×ÛÊö¡£
1.  Ð¡RNAµÄ¸Å¿ö¼°Ìصã
1.1 siRNA
RNA¸ÉÉæ£¨RNAi£©ÔÚʵÑéÊÒÖÐÊÇÒ»ÖÖÇ¿´óµÄʵÑ鹤¾ß£¬Í¨¹ýÕâÖÖ·½Ê½£¬ÀûÓþßÓÐͬԴÐÔµÄË«Á´RNA£¨dsRNA£©ÓÕµ¼ÐòÁÐÌØÒìµÄÄ¿±ê»ùÒòµÄ³Á¼Å£¬Ñ¸ËÙ×è¶Ï»ùÒò»îÐÔ¡£Ð¡µÄ¸ÉÉæRNA£¨siRNA£©ÊÇÔÚRNA¸ÉÉæ¹ý³ÌÖÐÈ˹¤ÌåÍâºÏ³ÉµÄСƬ¶ÎRNA£¬ÓÉÔ¼20¸ö¼î»ù¶Ô×é³É£¬°üÀ¨5¸öÁ×ËáÑΣ¬2¸öºËÜÕºÍ3¸öÐü±Û¡£SiRNAÔÚRNA³Á¼ÅͨµÀÖÐÆðÖÐÐÄ×÷Óã¬ÊǶÔÌØ¶¨ÐÅʹRNA£¨mRNA£©½øÐнµ½âµÄÖ¸µ¼ÒªËØ¡£1999Äê, HamiltonµÈÔÚÖ²Îï»ùÒò³ÁĬµÄÑо¿ÖÐÊ״η¢ÏÖ21¡«25nt µÄdsRNA µÄ³öÏÖ¶Ôת»ùÒòµ¼Ö»ùÒò³ÁĬʮ·ÖÖØÒª,¶øÔÚת»ùÒòÕýÈ·±í´ïµÄÖ²ÖêÖÐÔòδ³öÏÖ¡£Ëæºó,Hammond µÈ½øÐеÄϸ°ûÌáÈ¡ÎïºËËáø»îÐÔʵÑéÖ¤Ã÷ÁËС·Ö×ÓRNAÔÚRNAi ÖеÄ×÷Óã¬ÕâЩС·Ö×ÓRNA¾ÍÊÇÓÉdsRNAÐγɵÄsiRNA¡£siRNA µÄ3´-Ä©¶Ë2-nt µÄÍ»³ö¶Ô°Ðµãʶ±ðµÄÌØÒìÐÔÆðÒ»¶¨µÄ×÷ÓÃ,¿É½«ÆäÏÞ¶¨ÔÚµÚÒ»¸ö¼î»ù¶ÔÏàÁڵIJ»³É¶Ô¼î»ùµÄλÖá£×î½üµÄ¡¶nature¡·ÖÜ¿¯±¨µÀÁËÁ½¸öÑо¿Ð¡×éÒÔÊýÒÔǧ¼ÆµÄÈËÀàºÍÀÏÊó»ùÒòΪĿ±ê´´½¨RNAi¿âµÄ½øÕ¹£¬¿ÆÑ§½øÕ¹ÒÑÇåÎúµØ±íÃ÷£ºÔÚ²¸È鶯ÎïÖÐÀûÓÃСµÄ¸ÉÉæRNAºÍ¶Ì·¢¼ÐRNA£¨short hairpin RNAs,shRNA£©À´½øÐÐRNA¸ÉÉæÒÔʹ»ùÒò³Á¼ÅÒѾ­³ÉΪǿ´ó¶øÓÐÁ¦µÄÉúÎ﹤¾ß¡£
1.2 miRNA
miRNAµÄÑо¿ÆðʼÓÚʱÐòµ÷¿ØÐ¡RNA£¨stRNAs£©¡£1993Ä꣬LeeµÈÔÚÐãÀöÐÂС¸ËÏ߳棨Caenorhabditis elegan£©Öз¢ÏÖÁ˵ÚÒ»¸ö¿ÉʱÐòµ÷¿ØÅßÌ¥ºóÆÚ·¢ÓýµÄ»ùÒòlin-4,2002Ä꣬ReinhartµÈÓÖÔÚÏß³æC.eleganÖз¢ÏÖµÚ¶þ¸öÒìʱÐÔ¿ª¹Ø»ùÒòlet-7£¬2001Äê10Ô¡¶science¡·±¨µÀÁËÈý¸öʵÑéÊÒ´ÓÏ߳桢¹ûÓ¬ºÍÈËÌå¿Ë¡µÄ¼¸Ê®¸öÀàËÆC.eleganµÄlin-4µÄСRNA»ùÒò£¬³ÆÎªmicroRNA¡£MicroRNA£¨miRNA,΢RNA£©¼´Îª³¤¶ÈΪ22nt×óÓÒµÄ5´¶Ë´øÁ×Ëá»ùÍÅ¡¢3´¶Ë´øôÇ»ùµÄ·Çµ°°×±àÂëµÄµ÷¿ØÐ¡RNA¼Ò×å¡£
Ö²ÎïmiRNA´Ó2002ÄêÆð²ÅÓб¨µÀ£¬±àÂëÖ²ÎïmiRNAsµÄ»ùÒòÃ÷ÏÔ²»Í¬ÓÚÆäËûÉúÎÕâÑù£¬Ö²Îï±àÂëmiRNA»ùÒòµÄת¼²úÎï¿ÉÄܸü´ó£¬Ö²ÎïµÄmiRNAÓ뻥²¹½á¹¹µÄ´íÅäÒ»°ãÒ²ÉÙÓÚ¶¯ÎËùÒÔÔÚ½ø»¯ÉÏÒ²¸üΪ±£ÊØ¡£µ«ºÍ¶¯ÎïmiRNAÒ»Ñù£¬miRNAµÄת¼²úÎïÒ²ÊÇ·¢¼Ð×´½á¹¹£¬ÔÚRNase¢óøÇкóÒÔË«Á´ÐÎʽ´æÔÚ£¬×îºóÊÍ·Å»¥²¹Á´£¬miRNA³ÉÊì¡£
miRNA¹ã·º´æÔÚÓÚÕæºËÉúÎïÖУ¬²»¾ßÓпª·ÅÔĶÁ¿ò¼Ü£¬²»±àÂëµ°°×ÖÊ£¬Ò»°ã³¤20-24nt£¬µ«ÔÚÄâÄϽæºÍÑ̲ÝÖз¢ÏÖ26ntµÄRNA£¬ËÄĤ³æ(Tetrahymenas)Öз¢ÏÖ28ntµÄmiRNA¡£³ÉÊìµÄmiRNA 5´¶ËµÄÁ×Ëá»ùÍźÍ3´¶ËôÇ»ùÔòÊÇËüÓëÏàͬ³¤¶ÈµÄ¹¦ÄÜRNA½µ½âƬ¶ÎµÄÇø·Ö±êÖ¾¡£
Ðí¶àmiRNAµÄ»ùÒò½á¹¹¼°¹¦ÄÜÔÚ½ø»¯ÖÐÓб£ÊØÐÔ£¬Ô¼12%µÄmiRNAÔÚÏ߳桢¹ûÓ¬¡¢Ö²Îï¼°²¸È鶯ÎïÖб£ÊØÇÒ±£ÊØÆ¬¶ÎµÄ²îÒì½öΪ1-2nt¡£ÔÚÏß³æC.eleganÖÐËù·¢ÏÖµÄmiRNA85%¶¼¿ÉÒÔÔÚC.briggsarµÄ»ùÒò×éÖÐÕÒµ½Í¬Ô´ÐòÁС£Ï¸°ûÌØÒìÐÔ»ò×éÖ¯ÌØÒìÐÔÊÇmiRNAµÄ±í´ïµÄÖ÷ÒªÌØµã£¬ÈçÄâÄϽæÖеÄmiR-171½öÔÚÆä»¨ÐòÖиßˮƽ±í´ï£¬ÔÚijЩ×éÖ¯µÍˮƽ±í´ï£¬ÔÚ¾¥¡¢Ò¶µÈ×éÖ¯ÖÐÈ¥ÎÞÈκαí´ïµÄ¼£Ïó£»ÓÖÈç20-24hµÄ¹ûÓ¬ÅßÌ¥ÌáÈ¡ÎïÖпɷ¢ÏÖmiR-12,È´ÕÒ²»µ½miR3-miR6,ÔÚ³ÉÄê¹ûÓ¬Öбí´ïµÄmiR-1ºÍlet-7Ò²ÎÞ·¨ÔÚ¹ûÓ¬ÅßÌ¥Öбí´ï£¬ÕâͬʱÌåÏÖÁËmiRNAµÄÓÖÒ»ÌØµã¡ª¡ª»ùÒò±í´ïʱÐòÐÔ¡£MiRNA±í´ïµÄʱÐòÐÔºÍ×éÖ¯ÌØÒìÐÔÌáʾÈËÃÇmiRNAµÄ·Ö²¼¿ÉÄܾö¶¨×éÖ¯ºÍϸ°ûµÄ¹¦ÄÜÌØÒìÐÔ£¬Ò²¿ÉÄܲÎÓëÁ˸´ÔӵĻùÒòµ÷¿Ø£¬¶Ô×éÖ¯µÄ·¢ÓýÆðÖØÒª×÷Óá£
1.3ÆäËûСRNA
ÔÚÉúÎïÌåÖУ¬´æÔÚÒ»À಻ͬÓÚmiRNAºÍsiRNAµÄСRNA£¬³¤¶ÈÔÚ20-28ntÖ®¼ä¡£ÕâÀàRNAµÄ½á¹¹¡¢Éú³É¡¢¹¦ÄÜδ֪¡£ÍƲâ¿ÉÄÜÀ´Ô´ÓÚdsRNAÁ½¼«£¬ÊDz»Í¬RNase¢óøµÄ²úÎï¡£
2.СRNAµÄÉú³É¼°×÷ÓûúÖÆ
2.1siRNAµÄÉú³É¼°×÷ÓûúÖÆ
siRNAÊÇRNAi;¾¶ÖеÄÖмä²úÎÊÇRNAi·¢»ÓЧӦËù±ØÐèµÄÒò×Ó¡£SiRNAµÄÐγÉÖ÷ÒªÓÉDicerºÍRde-1µ÷¿ØÍê³É¡£ÓÉÓÚRNA ²¡¶¾ÈëÇÖ¡¢×ª×ù×Óת¼¡¢»ùÒò×éÖз´ÏòÖØ¸´ÐòÁÐת¼µÈÔ­Òò,ϸ°ûÖгöÏÖÁËdsRNA£¬Rde-1(RNAiȱÏÝ»ùÒò-1)±àÂëµÄµ°°×ÖÊʶ±ðÍâÔ´dsRNA£¬µ±dsRNA´ïµ½Ò»¶¨Á¿µÄʱºò£¬Rde-1Òýµ¼dsRNAÓëRde-1±àÂëµÄDicer£¨DicerÊÇÒ»ÖÖRNaseIII »îÐÔºËËáÄÚÇÐø£¬¾ßÓÐËĸö½á¹¹Óò£ºArgonaute¼Ò×åµÄPAZ½á¹¹Óò£¬IIIÐÍRNAø»îÐÔÇøÓò£¬dsRNA½áºÏÇøÓòÒÔ¼°DEAH/DEXHRNA½âÐýø»îÐÔÇø£©½áºÏ£¬ÐγÉø-dsRNA¸´ºÏÌå¡£ÔÚ
DicerøµÄ×÷ÓÃÏ£¬Ï¸°ûÖеĵ¥Á´°ÐmRNA£¨ÓëdsRNA¾ßÓÐͬԴÐòÁУ©ÓëdsRNAµÄÕýÒåÁ´»¥»»£¬Ô­À´dsRNAÖеÄÕýÒåÁ´±»mRNA´úÌæ¶ø´Óø-dsRNA¸´ºÏÎïÖÐÊͷųöÀ´£¬È»ºó£¬ÔÚATPµÄ²ÎÓëÏ£¬Ï¸°ûÖдæÔÚµÄÒ»ÖÖRNAÓÕµ¼µÄ³ÁĬ¸´ºÏÌåRNA-induced silencing complex £¨RISC£¬ÓɺËËáÄÚÇÐø¡¢ºËËáÍâÇÐø¡¢½âÐýøµÈ¹¹³É£¬×÷ÓÃÊǶ԰ÐmRNA½øÐÐʶ±ðºÍÇиÀûÓýáºÏÔÚÆäÉϵĺËËáÄÚÇÐøµÄ»îÐÔÀ´ÇиîdsRNAÉÏ´¦ÓÚÔ­À´ÕýÒåÁ´Î»ÖõİÐmRNA·Ö×ÓÖÐÓëdsRNA·´ÒåÁ´»¥²¹µÄÇøÓò£¬ÐγÉ21-23ntµÄdsRNAСƬ¶Î£¬ÕâЩСƬ¶Î¼´ÎªsiRNA¡£
RNAi¸ÉÉæµÄ¹Ø¼ü²½ÖèÊÇ×é×°RISCºÍºÏ³É½éµ¼ÌØÒìÐÔ·´Ó¦µÄsiRNAµ°°×¡£SiRNA²¢ÈëRISCÖУ¬È»ºóÓë°Ð±ê»ùÒò±àÂëÇø»òUTRÇøÍêÈ«Åä¶Ô£¬½µ½â°Ð±ê»ùÒò£¬Òò´Ë˵siRNAÖ»½µ½âÓëÆäÐòÁл¥²¹Åä¶ÔµÄmRNA¡£Æäµ÷¿ØµÄ»úÖÆÊÇͨ¹ý»¥²¹Åä¶Ô¶ø³ÁĬÏàÓ¦°Ðλ»ùÒòµÄ±í´ï£¬ËùÒÔÊÇÒ»ÖÖµäÐ͵ĸºµ÷¿Ø»úÖÆ¡£
siRNAʶ±ð°ÐÐòÁÐÊÇÓи߶ÈÌØÒìÐԵ쬵«Õâ²¢²»ÊÇ˵·´ÒåÁ´ÉÏËùÓеļî»ù¶¼¶Ô·¢»ÓÕâÖÖÌØÒìÐÔÆðµ½ÁËÏàͬµÄ×÷Óá£ÒòΪ½µ½âÊ×ÏÈÔÚÏà¶ÔÓÚsiRNAÀ´ËµµÄÖÐÑëλÖ÷¢Éú£¬ËùÒÔÕâЩÖÐÑëµÄ¼î»ùλµã¾ÍÏԵü«ÎªÖØÒª£¬Ò»µ©·¢Éú´íÅä¾Í»áÑÏÖØÒÖÖÆRNAiµÄЧӦ£¬Ïà¶Ô¶øÑÔ£¬3´Ä©¶ËµÄºËÜÕËáÐòÁв¢²»ÒªÇóÓë°ÐmRNAÍêȫƥÅä¡£
2.2 miRNAµÄÐγɼ°×÷ÓûúÖÆ
Æù½ñµÄÑо¿ÈÏΪ£¬miRNA¿ÉÄܵÄÐγɼ°×÷ÓûúÖÆÎª£ºÏÈÓɳ¤µÄÄÚÔ´ÐÔת¼±¾£¨pri-miRNA£©Éú³É70nt×óÓÒµÄmiRNAǰÌ壨pre-miRNA£©£¬È»ºóÔÚDicerøµÄ×÷ÓÃÏÂʹÆä¼Ó¹¤³ÉΪһ¸ö²»Îȶ¨µÄdsRNA·Ö×Ó£¬½Ó×ÅѸËÙ±»½µ½â¼ôÇÐΪ22nt×óÓҵĵ¥Á´RNA£¨ÕâÖÖµ¥Á´RNA¼°ÒÔºóµÄmiRNAÖ»ÊÇDicer×÷ÓÃÏÂpre-miRNA±»¼ôÇеÄÒ»¸ö±Û£¬¿ÉÄÜÊÇ3´¶ËµÄÒ»¸ö±Û£¬Ò²¿ÉÄÜÊÇ5´¶ËµÄÒ»¸ö±Û£¬²»Í¬RNA¿ÉÄÜÊÇͬһpre-miRNAµÄ²»Í¬±Û£©£¬Ö®ºó±»PPD(PAZ&Piwi domain)µ°°×¼Ò×åʶ±ð£¬ÐγÉRNA-µ°°×Öʸ´ºÏÌå¼´miRNAºËµ°°×Ì壨miRNP£©,½ø¶øÐγɳÉÊìµÄmiRNA¡£miRNAʶ±ð²¢Óë°Ð±ê»ùÒò3´UTRÇø²¿·ÖÅä¶Ô£¬´Ó¶øÒÖÖÆ°Ð±ê»ùÒòµÄ·­Òë¡£
miRNA»ùÒòÊÇÒ»Àà¸ß¶È±£ÊصĻùÒò¼Ò×壬°´Æä×÷ÓÃģʽ²»Í¬¿É·ÖΪÈýÖÖ£ºµÚÒ»ÖÖÒÔÏß³ælin-4Ϊ´ú±í£¬×÷ÓÃʱÓë°Ð±ê»ùÒò²»ÍêÈ«»¥²¹½áºÏ£¬½ø¶ø×è¶ô·­Òë¶ø²»Ó°ÏìmRNAµÄÎȶ¨ÐÔ£¬ÕâÖÖmiRNAÊÇĿǰ·¢ÏÖ×î¶àµÄÖÖÀà¡£µÚ¶þÖÖÒÔÄâÄϽæmiR-171Ϊ´ú±í£¬×÷ÓÃʱÓë°Ð±ê»ùÒòÍêÈ«»¥²¹½áºÏ£¬×÷Ó÷½Ê½ºÍ¹¦ÄÜÓësiRNA·Ç³£ÀàËÆ£¬×îºóÇиî°ÐmRNA,Õâ˵Ã÷ijЩmiRNAºÍsiRNAÒ»Ñù²ÎÓëÁË»úÌåÄÚÒ»Ð©ÌØÒìÐÔmRNAµÄ¼ôÇйý³Ì¡£µÚÈýÖÖÒÔlet-7Ϊ´ú±í£¬Ëü¾ßÓÐÒÔÉÏÁ½ÖÖ×÷ÓÃģʽ£¬µ±Óë°Ð±ê»ùÒòÍêÈ«»¥²¹½áºÏʱ£¬Ö±½Ó°ÐÏòÇиîmRNA£¬Èç¹ûÓ¬ºÍHelaϸ°ûÖÐlet-7Ö±½Ó½éµ¼RISC·ÖÁÑÇиî°ÐmRNA£»µ±Óë°Ð±ê»ùÒò²»ÍêÈ«»¥²¹½áºÏʱ£¬Æðµ÷½Ú»ùÒò»ùÒò±í´ïµÄ×÷Óã¬ÈçÏß³æÖеÄlet-7Óë°ÐmRNA3´¶Ë·Ç·­ÒëÇø²»ÍêÈ«Åä¶Ô½áºÏºó£¬×è¶ôµ÷½Ú»ùÒòµÄ·­Òë¡£
¿ÆÑ§¼ÒÃÇÒÑ·¢ÏÖmiRNAÔÚ¶¯Ö²ÎïÔçÆÚ·¢ÓýÖÐÆðµÄ¹Ø¼üµ÷½Ú×÷Ó㬰üÀ¨Ö²ÎïÒ¶¡¢»¨µÄ·¢Éú£¬¶¯ÎïÅßÌ¥¼°×éÖ¯·¢ÓýµÈ£¬BrenneckeµÈÈËÀûÓõçÄÔѰÕҰбê»ùÒò£¬Ö¤ÊµÁËmiRNA²»ÍêÈ«½áºÏ
3´UTRÖдæÔÚϸ°ûËÀÍöÓÕµ¼»ùÒò£¬ÕâÌáʾ˵Ã÷miRNA¶ÔÉú³¤·¢Óý½øÐиüÎªÖØÒªµÄµ÷¿Ø×÷Óá£Í¬Ê±£¬¿ÆÑ§¼ÒÃÇÒ²·¢ÏÖÈËÀà»ùÒò×éÖдóÔ¼ÓÐ255¸ö±àÂëmiRNA»ùÒò£¬Ô¼Õ¼ÈËÀà»ùÒòÊýµÄ1%£¬µ«Éв»Çå³þÆä¹¦ÄÜ¡£
3. siRNAÓëmiRNAµÄ¹ØÏµ
siRNAºÍmiRNAÔÚ¹¦ÄܺÍ×÷ÓûúÖÆÉÏÓкܴóµÄÏàËÆÐÔ£¬µ«Í¬Ê±ÔڽṹµÈ·½ÃæÓÖÓкܴóµÄÇø±ð£¬ÔÚ½ø»¯É϶þÕߵĹØÏµÒ²ÉÐÎÞ½áÂÛ¡£
3.1 miRNAÓësiRNAµÄÏàͬµã
miRNAÓësiRNAÖ®¼äÓÐÐí¶àÏà֮ͬ´¦£¬¾ßÌåÈçÏ£º
a.  ¶þÕߵij¤¶È¶¼Ô¼ÔÚ22nt×óÓÒ¡£
b.  ¶þÕß¶¼ÒÀÀµDicerøµÄ¼Ó¹¤£¬ÊÇDicerµÄ²úÎËùÒÔ¾ßÓÐDicer²úÎïµÄÌØµã¡£
c.  ¶þÕßÉú³É¶¼ÐèÒªArgonaute¼Ò×åµ°°×´æÔÚ¡£
d.  ¶þÕß¶¼ÊÇRISC×é·Ö£¬ËùÒÔÆä¹¦ÄܽçÏÞ±äµÃ²»ÇåÎú£¬Èç¶þÕßÔڽ鵼³ÁĬ»úÖÆÉÏÓÐÖØµþ¡£
e.  miRNAºÍsiRNAºÏ³É¶¼ÊÇÓÉË«Á´µÄRNA»òRNAǰÌåÐγɵġ£
3.2 miRNAÓësiRNAµÄ²»Í¬µã
a.  ¶þÕߵĸù±¾Çø±ðÊÇmiRNAÊÇÄÚÔ´µÄ£¬ÊÇÉúÎïÌåµÄ¹ÌÓÐÒòËØ£»¶øsiRNAÊÇÈ˹¤ÌåÍâºÏ³ÉµÄ£¬Í¨¹ýתȾ½øÈëÈËÌåÄÚ£¬ÊÇRNA¸ÉÉæµÄÖмä²úÎï¡£
b.  ÔڽṹÉÏ£¬miRNAÊǵ¥Á´RNA£¬¶øsiRNAÊÇË«Á´RNA¡£
c.  Dicerø¶Ô¶þÕߵļӹ¤¹ý³Ì²»Í¬£¬miRNAÊDz»¶Ô³Æ¼Ó¹¤£¬miRNA½öÊǼôÇÐpre-miRNAµÄÒ»¸ö²à±Û£¬ÆäËû²¿·Ö½µ½â£»¶øsiRNA¶Ô³ÆµØÀ´Ô´ÓÚË«Á´RNAµÄǰÌåµÄÁ½²à±Û¡£
d.  ÔÚ×÷ÓÃλÖÃÉÏ£¬miRNAÖ÷Òª×÷ÓÃÓڰбê»ùÒò3´-UTRÇø£¬¶øsiRNA¿É×÷ÓÃÓÚmRNAµÄÈκβ¿Î»¡£
e.  ÔÚ×÷Ó÷½Ê½ÉÏ£¬miRNA¿ÉÒÖÖÆ°Ð±ê»ùÒòµÄ·­Ò룬Ҳ¿ÉÒÔµ¼Ö°бê»ùÒò½µ½â£¬¼´ÔÚת¼ˮƽºóºÍ·­ÒëˮƽÆð×÷Ó㬶øsiRNAÖ»Äܵ¼Ö°бê»ùÒòµÄ½µ½â£¬¼´Îª×ªÂ¼Ë®Æ½ºóµ÷¿Ø¡£
f.  miRNAÖ÷ÒªÔÚ·¢Óý¹ý³ÌÖÐÆð×÷Ó㬵÷½ÚÄÚÔ´»ùÒò±í´ï£¬¶øsiRNA²»²ÎÓëÉúÎïÉú³¤£¬ÊÇRNAiµÄ²úÎԭʼ×÷ÓÃÊÇÒÖÖÆ×ª×ù×Ó»îÐԺͲ¡¶¾¸ÐȾ¡£
3.3 miRNAÓësiRNAµÄ½ø»¯¹ØÏµ
miRNAÓësiRNAÔÚ¼Ó¹¤»úÖÆÉϵÄÏàËÆÐÔʹ¶þÕߵĽçÏÞÒѾ­Ô½À´Ô½²»Ã÷ÏÔÁË¡£¶þÕßÔÚ½ø»¯¹ØÏµÉÏÊÇ´ÓÊô¹ØÏµ»¹ÊÇÆ½ÐйØÏµ£¬ËüÃǵĽø»¯Ë³ÐòÊÇʲô£¬Õâ¶¼ÒýÆðÁËÉúÃü¿ÆÑ§ÁìÓòµÄ¹ã·ºÕùÂÛ£¬ÇÒĿǰÉÐÎÞ¶¨ÂÛ¡£HutvagnerºÍZamoreͨ¹ýÊÔÑ飬ÈÏΪmiRNA»òsiRNAµÄ¹¦ÄÜ·¢»ÓÈ¡¾öÓÚËüÓë°Ð±ê»ùÒò½áºÏλµãµÄÆ¥Åä³Ì¶È£¬¶øÓÃÓÚʶ±ðmiRNAµÄPPD¼Ò×åµÄºÜ¶à³ÉԱΪRISCµÄ×é·Ö£¬ÕâÑù£¬¶þÕߵĽçÏÞÔò¸üΪģºý£¬ËüÃÇ¿ÉÄܲ¢²»´æÔÚ±¾ÖʵÄÇø±ð£¬¾Í´ËÒâÒåÉϽ²£¬siRNAËÆºõÊÇmiRNAµÄÒ»¸ö²¹³ä¡£ÔÚ½ø»¯Ë³ÐòÉÏ£¬ÎÒ¸öÈËÇãÏòÓÚmiRNAÏÈÓÚsiRNA£¬¾¡¹ÜÓÐЩÈËÈÏΪÍâÔ´»ùÒòÓ¦ÔçÓÚÉúÎï½ø»¯³öÏÖ£¬µ«ÊÇsiRNAÊÇÒ»ÖÖ¸ÉÉæRNAµÄÖнé²úÎËü±ØÐëÓв¡¶¾»òÊÇÆäËûË«Á´RNAÓÕµ¼²ÅÄÜÐγɣ¬ÇÒsiRNAµÄ×è¶ô·½Ê½¹ýÓÚ³¹µ×£¬Ó¦¸ÃÊÇÉúÃü·¢Õ¹µ½Ò»¶¨³Ì¶Èºó²Å²úÉúµÄ¡£
4.СRNAµÄʶ±ð¡¢Êý¾Ý¿â½¨Éè¼°×îнøÕ¹
ÔÚÕæºËÉúÎïСRNA»ùÒòµÄ¼ÆËã»úʶ±ðÉÏ£¬ÂéÊ¡Àí¹¤Ñ§ÔºµÄLimС×鿪·¢Ð¡RNA»ùÒòÔ¤²â³ÌÐòMiRscanÆÀ·Öϵͳ£¬½ø¶ø¶ÔÈËÀàºÍÏß³æµÄ»ùÒò½øÐÐ̽Ë÷£¬È·¶¨Ð¡RNA·ÖÊôµÄ¼Ò×å¼°±£ÊØÐÔÖÊ¡£
¡¶nature¡·ÖÜ¿¯½üÆÚ±¨µÀÁËÔÚRNA¸ÉÉæ¹ý³ÌÖÐÀûÓÃPAZÓò¶ÔsiRNA½øÐÐʶ±ð£¬·½·¨Êǽ«siRNAµÄÈý¸öÐü±Û¹Ì¶¨¡£µ«ÊÇPAZ¿ÉÄܲ»ÊÇÔÚRNA¸ÉÉæÖеÄΨһʶ±ð·½Ê½¡£
Patrick.J.PaddisonµÈÈ˵ÄÁ½¸öÑо¿Ð¡×鱨¸æÁËÒÔÊýÒÔǧ¼ÆµÄÈËÀàºÍÀÏÊóΪĿ±êµÄRNAi¿âµÄ´´½¨£¬ÔÚ²¸È鶯ÎïÖжÔСRNAµÄÑо¿½«Ê¹ÆäÓÐÓг¤×ã½ø²½¡£
5Ô³ö°æµÄScience±¨µÀÁËÓÉEB²¡¶¾±àÂëµÄ΢RNAi£¬ÕâÊÇÒ»Ïîȫеķ¢ÏÖ¡£ÒòΪ´ó¼ÒÖªµÀRNAi¼¼ÊõµÄǰÌáÊÇË«Á´µÄ¶ÌRNA£¬¶ø²¡¶¾ÔòÊǵ¥Á´µÄDNA/RNA¡£ÕâÒ»Ñо¿³É¹û½«ÎªRNAiÓ¦ÓÃÌṩÁ˸ü¹ãÀ«µÄǰ¾°¡£
ÔÚ»ùÒò²Ù×÷½ÏÀ§ÄѵÄÉñ¾­ÔªÖУ¬ÒÑÓгɹ¦½øÐÐRNAiµÄ±¨µÀ¡£KrichevskyµÈ½«»¯Ñ§ºÏ³ÉµÄ21nt siRNAͨ¹ýÑôÀë×ÓÖ¬ÀàתȾÊÔ¼Áµ¼ÈëÔ­´úÅàÑøµÄ´óÊóÉñ¾­Ôª£¬ÏÔÖøÒÖÖÆÄÚÔ´°Ð»ùÒòºÍתȾ»ùÒòµÄ±í´ï¡£ÒÖÖÆÉñ¾­ÔªNOºÏ³Éø±í´ïÄÜÓÐЧ½µµÍÌÛÍ´£¬ÔÚKorneevµÄʵÑéÖÐÉè¼ÆµÄË«Á´RNA³É¹¦µØÒÖÖÆÁËÖÐÊàÉñ¾­ÏµÍ³NOºÏ³Éø±í´ï£¬»ñµÃRNA¸ÉÈŵijɹ¦¡£RNAiÄÜÔÚ¼«µÍŨ¶È£¨nmol·¶Î§£©siRNA´æÔÚÏÂÏÔʾ³öÌØÊâÓÐЧÐÔ¡£
¹ã¶«Ê¡¿Æ¼¼¹¥¹ØÏîÄ¿¡°·ÀÖÎSARS¼²²¡ÌØÐ§siRNAÒ©ÎïÑо¿¡±¿ÎÌâ×é2003Äê6Ô¿ªÊ¼Õë¶ÔSARS¹Ú×´²¡¶¾µÄRNA»ùÒò×éÌØ¶¨°Ðλµã×ÔÐÐÉè¼ÆÁ˹²48ÌõË«Á´RNAС·Ö×Ó£¬Í¨¹ýÌåÍâϸ°ûʵÑéϵͳ³É¹¦µØÉ¸Ñ¡³öÁË4Ìõ¶ÔSARS¹Ú×´²¡¶¾ÓÐЧµÄË«Á´RNAС·Ö×Ó£¬ÕâЩ˫Á´RNAС·Ö×ÓÔÚÌåÍâÅàÑøÏ¸°ûÖÐÄÜÌØÒìµØÇҷdz£ÓÐЧµØ×è¶ÏSARS¹Ú×´²¡¶¾µÄ¸ÐȾ¼°²¡¶¾ÔöÖ³¡£ÆäÔ¤·ÀSARS¹Ú×´²¡¶¾µÄЧ¹û´ïµ½90%ÒÔÉÏ,¼¸¸öÓÐЧµÄË«Á´RANС·Ö×ÓÁªºÏʹÓÃÆäÖÎÁÆÐ§¹û´ïµ½80%ÒÔÉÏ£¬¶øÇÒʵÑé½á¹û¾ùµÃµ½Öظ´ÑéÖ¤¡£¾­¹ýsiRNAÔ¤·À»òÖÎÁƺó£¬Ô­À´¸ÐȾSARS¹Ú×´²¡¶¾µÄÂ̺ïÅßÉöϸ°û¶àÄܱ£³ÖÕý³£µÄϸ°ûÐÎ̬ºÍÊýÄ¿¡£
5.¶ÔСRNA»ùÒòµÄÌÖÂÛ¼°Õ¹Íû
СRNAµÄÑо¿¸øÎÒÃÇ´øÀ´±ÈÆä±¾Éí¸üÎªÖØÒªµÄÆôʾÊÇ»ùÒò×é·Ç×éµ°°×±àÂëÇøÔ̺¬×ÅÖØÒªµÄÉúÃü¹¦ÄܻÐÅÏ¢¡£ÉúÃüµÄÒ»Ð©ÖØÒª»î¶¯ÈçÓ׳æµÄÉú³¤·¢Óý¡¢Ï¸°ûµÄ·¢ÉúºÍ·Ö»¯¡¢Éñ¾­ÏµÍ³µÄ·Ö»¯µÈ¶¼±»Ò»Ð©·Çµ°°×±àÂëСRNAµÄµ÷¿Ø£»¶ø³ýmiRNA¡¢siRNAÒÔÍâµÄСRNAÎÒÃǸüÊÇÖªÖ®ÉõÉÙ¡£³¤ÆÚÒÔÀ´£¬·Ö×ÓÉúÎïѧÑо¿µÄÖØµã¶¼ÔÚµ°°×±àÂë»ùÒòÉÏ£¬¶øÐ¡RNAµÄ·¢ÏÖºÍÑо¿ÔòÌáʾÎÒÃÇÓ¦¸ÃÏà¶Ô¸ü¶àµØ´ÓÕâ·½ÃæÁ˽âÉúÃüµÄ°ÂÃØ£¬ÕâЩСRNA¿ÉÄܱàÂëÉúÃü»î¶¯µÄÖØÒªµ÷¿ØÔª¼þ¡£Óб¨µÀ³ÆÐ¡RNA¿ÉÓ°ÏìËÄĤ³æµÄϸ°û·ÖÁÑ£¬Èç¹û¸ÃÖÖСRNAÔÚÈËÀàÖдæÔÚ£¬Ôò¿ÉÄÜÓë°©Ö¢Óйأ¬2004Äê6Ô¡¶ÁÙ´²Ñо¿ÔÓÖ¾¡·ÉÏ·¢±íµÄÒ»ÏîʵÑéÊÒÑо¿£¬ siRNAËÆºõ¼ÓÇ¿ÁËÒÁÂíÌæÄᣨImatinib£©ºÍÀ×ÅÁÃ¹ËØµÄ¿¹°©×÷Ó᣶øÇÒ¾Ý˵£¬ÕâÖÖÖÎÁÆÔÚ³öÏÖÒ©ÎïÄÍÊÜÐÔÊ±ÌØ±ðÓаïÖú¡£SiRNA¿ÉÒÔͨ¹ýÓëHIV-1ϸ°ûÄÚÊÜÌåCD4£¬²¡¶¾½á¹¹µ°°×Gag»òÌæ´úNefµ÷½Úµ°°×µÄÂÌɫӫ¹âµ°°×µÄ°ÐmRNA×÷ÓÃÒÖÖÆ²¡¶¾²úÉú¡£SiRNAÄÜÓÐЧÒÖÖÆHIV-1ÉúÃüÖÜÆÚÖÐÕûºÏÇÖȾǰºóʼþ¡£ÕâÑù£¬siRNA¿ÉÄÜÓ¦Óõ½HIV-1ºÍÆäËû²¡¶¾ÇÖȾµÄÖÎÁƸÉÔ¤ÖС£siRNA¼¼Êõ¿ÉÄÜÓÃÓÚÒÖÖÆHIV-1ÔÚËÞÖ÷ϸ°ûÖеĸ´ÖƵÄÒ»ÖÖ¿ÉÄܵÄÖÎÁƲßÂÔ¡£ÀûÓÃСRNAÓÐЧÒÖÖÆ»ùÒò±í´ïµÄ»úÀí¿ÉÄÜΪÖÎÁƺܶಡ¶¾ÐÔ¼²²¡ºÍ»ùÒò¼²²¡Ñ°ÕÒеÄ;¾¶ºÍÍ»ÆÆ¿Ú¡£
СRNA»¹ÓÐÐí¶àÎÊÌâÐèÒªÎÒÃÇÈ¥Ñо¿£ºËüÃǵÄ×÷ÓûúÀí¾¿¾¹ÊÇʲô£¬¾ßÌåÓÐʲô¹¦ÄÜ£¬ËüÃÇͨ¹ýʲô;¾¶Ê¶±ð°Ð±ê»ùÒò£¬ËüÃǵÄÌØÒìÐÔºÍʱÐòÐÔÊÇÈçºÎµ÷¿ØµÄµÈµÈ¡£Ëæ×ÅÑо¿µÄÉîÈ룬Ëü½«ÎªÈËÀàÒÉÄѼ²²¡ÖÎÀíµÈ·½ÃæÆð¸üΪÉîÔ¶µÄ×÷Óá£×ÜÖ®£¬¶ÔСRNA»ùÒòµÄÑо¿½«ÊÇÉúÃü¿ÆÑ§ÁìÓòÑо¿µÄÈȵ㣬Ҳ½«ÊǽÒʾÉúÃü°ÂÃØµÄÓÖÒ»´óÀï³Ì±®¡£

²Î¿¼ÎÄÏ×
[1]Baulcombe D.ARNA microcosm.Science,2002,297(5589):2002-2003
[2]Calin G A,Dumityu C D,Shimizu M,et al.Small RNAs:the genome¡äs guiding hand? Nature,
2002,420(6917):732
[3]Chang-zheng Chen et al.MicroRNAModulate Hematopoietic Lineage Differentiation£¬Science£¬2004,303(5654):85-86
[4]Daisuke Shirane,Kohtaroh sugao,et al.Enzymatic production of RNAi libraries from cDNAs,Nature genetics,2004,36:190-196
[5]Dennis C.Gene regulation:The brave new world of RNA .Nature,2002,418(6894):122-124
[6]Dianne S.Schwarz et al.Asymmetry in the Assembly of the RNA:Enzyme Complex, Cell, 2003,115(2):199-208
[7]George Sen,Tom S Wehrman,Jason W Myers&Helen M Blau.Restriction enzyme-generated siRNA(REGS) vectors and libraries,Nature genetics,2004,36:183-189
[8]Hutvagner G,McLachlan J,Pasquinelli A E,et al.A cellular function for the RNA ¨Cinterferrnce enzyme dicer in the maturation of the let-7 small temporal RNA.Science,2001,293(5531):834-838
[9]Jeffrey M.Vargason.et al.Size selective Recognition of siRNA by an RNA sliencing Suppressor,Cell,2003,115(7):799-811
[10]Jin-Biao Ma,Keqiong Ye&Dinshaw.Patel.structural basis for overhang-specific small interfering RNA recognition by the PAZ domian,Nature,2004,429:318-322
[11]Kapranov P,Cawley S E,Drenkow J,er al.Large-scale transcriptional activity in chromosomes 21 and 22.Science,2002,296(5569):916-919
[12]Lee, N.S. et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cell. Nature Biotech. 2002£¬20£º500-505
[13]McManus M T,Sharp P A.Gene silencing in mammals by small interfering RNAs.Nature Reviews Genetics,2002,3(10):737-747
[14]McManus, M.T., Petersen, C.P., Haines, B.B., Chen, J. &Sharp, P.A. Gene silencing using micro-RNA designed hairpins. RNA £¬2002£¬8£º1-9
[15]Mourelatos Z,Dostie J,Paushkin S,et al.miRNPs:a novel class of riboncleoprotions containing numerous microRNAs.Genes&DEV,2002,16:720-728
[16]Patrick J.Paddisom,Jose M.Silva,Douglas S.Conklin ,et al.A rescource for large-scale RNA-interference-based screens in mammals,Nature,2004,428:427-431
[17]Reinhart B J,Bartel D P.Small RNAs correapond to centromere heterochromatic repeats. Science,2002,297(5588):1831
[18]Soraya Yekta,l-hung Shih,David P.Bartel.MicroRNA-Directed Cleavage of HOXB8 mRNA,Science,2004,304(5670):594-596
[19]Victor Ambros.MicroRNA Pathways in Files and Worms:Growth,Death,Fat,Stress,and timing,Cell,2003,113:673-676
[20]Xuemei Chen.A MicroRNA as Translational Repressor of APETALAZ in Arabidopsis Flower Development,Science,303(5660):2022-2025
[21]²Ì×Ó΢µÈ.NSÌØÒìÐÔsiRNAÕæºË±í´ïÔØÌåµÄ¹¹½¨.ĵµ¤½­Ò½Ñ§ÔºÑ§±¨.2003£¬24£¨3£©£º1-4
[22]³ÂÓ±£¬ÖìÃ÷»ª. RNA¸ÉÈÅ.ÖйúÉúÎ﹤³ÌÔÓÖ¾.2003£¬23£¨3£©£º39-43
[23]¶Å÷¾ý£¬ÁõµÂÅ࣬ÁºÖ²È¨. RNA¸ÉÈÅÓëȾɫÖʳÁĬ. ÉúÎﻯѧÓëÉúÎïÎïÀí½øÕ¹.2004£¬31£¨3£©£º204-207
[24]¹ùÏþºì£¬ÖÜÖÒТ¡£×ªÂ¼ºóˮƽµÄ»ùÒò³ÁĬ¡ªRNA¸ÉÉæ.»ù´¡Ò½Ñ§ÓëÁÙ´².2003£¬23£¨1£©£º24-28
[25]Àî¼Ìϼ£¬ÖÜ¿ËÔª.miRNAµÄÑо¿½øÕ¹.ÉúÎﻯѧÓëÉúÎïÎïÀí½øÕ¹.2003£¬30£¨5£©£º702-705
[26]ÂíÅôÅô£¬Ñ¦¶ÅÆÕ£¬º«´úÊé. RNA¸ÉÈż¼Êõ¼°ÆäÓ¦ÓÃ.Öйú×éÖ¯»¯Ñ§¼°Ï¸°û»¯Ñ§ÔÓÖ¾.2003£¬ 12£¨2£©£º201-207
[27]Éòά¸É. RNA¸ÉÈŵÄÑо¿·½·¨.ʵÓÃÁÙ´²Ò½Ò©ÔÓÖ¾.2003£¬7£¨1£©£º75-77
[28]Íô֮ĭ£¬ÁÎÁá½à. RNA¸ÉÉæºÍ»ùÒò³Á¼Å.¹úÍâҽѧÒÅ´«Ñ§·Ö²á.2003£¬26£¨3£©£º129-132
[29]Ҷ³ÂÔ¾ÀÚ£¬Ã÷Õòå¾. miRNA£¨MicroRNA£©¼Ò×åµÄÑо¿½øÕ¹. ÉúÎﻯѧÓëÉúÎïÎïÀí½øÕ¹.2003£¬30£¨3£©£º370-374
[30]Ò¶ÒàÖÛ£¬ÍõÒÔÕþ£¬¹ù°®¿Ë. RNA¸ÉÈż¼Êõ¼°ÆäÓ¦ÓÃ.ÉúÃüµÄ»¯Ñ§.2002£¬22£¨6£©£º503-506
[31]ÕÅÅô·É.siRNAµÄÉè¼Æ¡¢ºÏ³ÉÓëתȾ¼°ÆäÔÚRNA¸ÉÈÅÖеÄÓ¦ÓÃ.¹úÍâҽѧÁÙ´²ÉúÎﻯѧÓë¼ìÑéѧ·Ö²á.2003£¬24£¨4£©£º199-200
Progress in the Research of Small RNAs
Abstract: Small RNA gene and little interference RNA are main components of small RNA, their correlation is close, not only have similarity, but also have difference. Their important function point out to us albumen unencoding area contains extremely important information. The deep research of small RNAs will lead us to find out the secret of life.
Keywords:small RNAs,siRNA,miRNA, albumen unencoding area
¡¼ÓÞÓÞѧ԰¡½http://www.scifans.netÃâ·Ñ´úÀí|Ãâ·ÑÆÚ¿¯|ezproxy|ÎÄÏ×¼ìË÷|ѧÊõ×ÊÔ´|Ãâ·Ñ×ÊÔ´
2Â¥2005-06-05 21:00:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ìì±ßµÄÒ»Æ¬ÔÆ

ľ³æ (ÕýʽдÊÖ)

һЩ×ÊÁÏ

¡ï
miRNA(½ð±Ò+1):ºÃºÃÐ¡ÆøÑ½£¬ÔõôÕâôÉÙµÄ×ÊÁÏѽ£¡£¡
1.T-VETOR protocol
ÄÄÐж¼²»ºÃ¸É°¡
3Â¥2005-06-05 21:22:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ìì±ßµÄÒ»Æ¬ÔÆ

ľ³æ (ÕýʽдÊÖ)

2.RT-PCR protocol

¡ï ¡ï
miRNA(½ð±Ò+2):×ÜËã²¹³äÁË£¬Çë¼ÌÐø²¹³ä£¡£¡£¡
RT-PCR protocol
ÄÄÐж¼²»ºÃ¸É°¡
4Â¥2005-06-06 09:07:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ìì±ßµÄÒ»Æ¬ÔÆ

ľ³æ (ÕýʽдÊÖ)

Human RNA silences viral DNA(2005.4.26)

¡ï
miRNA(½ð±Ò+1):×ÜËã²¹³äÁË£¬Çë¼ÌÐø²¹³ä£¡£¡£¡
MicroRNA plays an unexpected role in the process, researchers report in Science | By Charles Q Choi

RNA silencing can defend against viruses in humans, French scientists report in this week's Science. Surprisingly, say the scientists, microRNA (miRNA) appears to form the basis of this system.

"MiRNAs were thought to be involved in the regulation of endogenous genes, whereas exogenous RNAs, in particular viral RNAs, were thought to be regulated by siRNA [small interfering RNA]," lead author Charles-Henri Lecellier at the Institute of Plant Molecular Biology in Strasbourg, France, told The Scientist.

Prior studies have revealed that RNA interference can destroy viruses in plants and insects, but a similar role in vertebrates has not been demonstrated. Since RNA silencing can suppress endogenous retroviruses from mobilizing in plants, yeast, worms, and flies, Lecellier and colleagues reasoned that retrotransposition of mammalian exogenous viruses might also prove vulnerable. They chose as their model system the primate foamy virus type 1, a retrovirus akin to HIV.

PFV-1 accumulation in cultured human embryonic kidney cells was strongly enhanced by the expression of the P19 silencing suppressor, suggesting that a siRNA or miRNA pathway limited PFV-1 replication in human cells, because P19 specifically binds to and inactivates both.

To identify the target and means of human RNA silencing, the investigators fused viral sequences spanning the PFV-1 genome to a green fluorescent protein (GFP)¨Ctagged reporter gene into constructs cotransfected with PFV-1 into baby hamster kidney cells. Northern and Western analysis revealed GFP levels from construct F11 were disproportionately reduced compared to F11 mRNA accumulation, which reminded researchers of miRNA translational inhibition. The DIANA-microT algorithm revealed a high probability match between the F11 sequence and the human miR-32.

Further studies demonstrated miR-32 silencing was suppressed in P19-expressing cells. Also, anti-miR-32 locked nucleic acid oligonucleotide almost doubled progeny virus production, unlike anti-miR-23, suggesting miR-32 has a direct, sequence-specific antiviral effect.

In plants and insects, all viruses targeted by RNA interference encode proteins that suppress RNA silencing. Further studies found that in PFV-1, Tas, a viral transactivator, was that protein.

In Arabidopsis, transgenic Tas expression strongly decreased siRNAs and led to developmental anomalies reminiscent of those elicited by suppressors interfering with miRNA functions, such as leaf elongation and serration, suggesting Tas suppresses a fundamental step conserved from plants to mammals shared between the miRNA and siRNA pathways.

Like Tas, another protein, AC2, encoded by the DNA plant viruses, geminiviruses, is a viral transactivator that can suppress RNA silencing. "We want to investigate whether transactivation and suppression are linked or completely separate," Lecellier said.

Researchers currently think each cell type harbors its own specific miRNA repertoire, Lecellier said. "This idea could partially explain some of the differences in viral permissivity observed between specific tissues," he said, with viruses preferentially replicating in cell types where antiviral miRNAs are not expressed or are only weakly expressed.

A miRNA response could also lead to the emergence of viral quasispecies, as viruses that can rapidly introduce synonymous mutations into their genomes, such as HIV or influenza, do so to evade silencing by miRNA. "The emergence of quasispecies is important for resistance to antiviral strategies, so studying this miRNA response could be important for studying resistance," Lecellier said.

The team saw no evidence that human cells used siRNAs to disable viruses. "So it'd be interesting to investigate whether or not mammals have lost the ability to respond to viruses using siRNAs because they have a more advanced immune system than plants and flies and worms," said Phillip Zamore at the University of Massachusetts, who did not participate in this study. It was uncertain whether the miRNAs were part of a dedicated antiviral response or whether they accidentally silenced viral RNA, he said. "It'd be interesting to see whether expression of miRNAs are vastly upregulated in viral infection," he told The Scientist.

Future directions should involve testing any of the several hundred human microRNAs against viruses such as HIV and influenza, said Shou-Wei Ding at the University of California at Riverside, who did not participate in this study. "Also, they studied this in cell culture, and it'd be interesting to look at this at the whole animal level," Ding told The Scientist.

Links for this article
C. Lecellier et al., "A cellular microRNA mediates antiviral defense in human cells," Science, 308:557-60. April 22, 2005.
http://www.sciencemag.org

Charles-Henri Lecellier
http://www.sigu7.jussieu.fr/B2M/pages/doc/2K4/virord11va.html

A.J. Hamilton, D.C. Baulcombe, "A species of small antisense RNA in posttranscriptional gene silencing in plants," Science, 286:950-2, October 29, 1999.
[PubMed Abstract:http://www.biomedcentral.com/pubmed/10542148/]

H. Li et al. "Induction and suppression of RNA silencing by an animal virus," Science, 296:1319-21, May 17, 2002.
[PubMed Abstract:http://www.biomedcentral.com/pub ... com/pubmed/12016316]  

C. Lecellier, A. Saib. "Foamy viruses: between retroviruses and pararetroviruses," Virology, 271:1-8, May 25, 2000.
[PubMed Abstract:http://www.biomedcentral.com/pub ... com/pubmed/10814564]  

Phillip Zamore
http://www.umassmed.edu/bmp/faculty/zamore.cfm

Shou-Wei Ding
http://www.cepceb.ucr.edu/members/ding.htm

    ¾Ý¡¶¿ÆÑ§¡·ÔÓÖ¾4ÔÂ23ÈÕ±¨µÀ£¬MicroRNAÔÚÈËÌå·¢Óý¹ý³ÌÖÐÆð×ÅÒâÏë²»µ½µÄ×÷Óá£

    ·¨¹ú¿ÆÑ§¼Ò³ÆºËÌǺËËá³ÁĬ»úÖÆ£¨RNA silencing£©Äܹ»µÖ¿¹ÈËÌåÖеIJ¡¶¾£¬²»¿É˼ÒéµÄÊÇ£¬Ð¡RNA (miRNA)¾¹È»ÊÇ×é³ÉÕâÒ»»úÖÆµÄ»ù´¡¡£

    ¡°¿ÆÑ§¼ÒÒ»Ö±ÈÏΪmiRNAÓëµ÷½ÚÄÚÔ´»ùÒòÓйأ¬¶øÐ¡·Ö×Ó¸ÉÈźËÌǺËËᣨiRNA£©Äܹ»¿ØÖÆÍâÔ´»ùÒò£¬ÓÈÆäÊDz¡¶¾RNA»ùÒò£¬¡±¸ÃÎĵÄÖ÷Òª×÷Õß¡¢À´×Ô·¨¹úË¹ÌØÀ­Ë¹±¤µÄÖ²Îï·Ö×ÓÉúÎïѧԺµÄ²éÀû˹¡¤ºàÀû¡¤À³Î÷ÀûÑÇÔÚ¡¶¿ÆÑ§¡·ÔÓÖ¾ÉÏ˵µÀ¡£

    ¿ÆÑ§¼ÒÃÇÏÈǰµÄÑо¿ÏÔʾ£¬ºËÌǺËËá¸ÉÈÅ£¨RNAi£©Äܹ»ÏûÃðÖ²ÎïÒÔ¼°À¥³æÌåÄڵIJ¡¶¾£¬µ«Ä¿Ç°»¹Ã»ÓÐÑо¿±íÃ÷ËüÔÚ¼¹×µ¶¯ÎïÒ²ÓµÓÐÀàËÆ¹¦ÄÜ¡£×Ô´Ó¿ÆÑ§¼ÒÃÇ·¢ÏÖRNA³ÁĬ»úÖÆÄܹ»Ñ¹ÒÖÄÚÉú·´×ªÂ¼²¡¶¾£¬Ê¹ÆäÎÞ·¨ÔÚÖ²Îï¡¢½Íĸ¡¢òÇò¾ÒÔ¼°²ÔÓ¬µÈµÈÌåÄÚÓζ¯£¬À³Î÷ÀûÑǺÍËûµÄͬʾÍÍÆ¶Ï²¸È鶯ÎïÌåÄÚµÄÍâÔ´²¡¶¾»ùÒòµÄ·´×ªÂ¼ÒÆÎ»¹¦ÄÜÓ¦µ±Ò²ÊÇͬÑù´àÈõ¡£Òò´ËËûÃÇÑ¡ÔñÁËÒ»ÖÖԭʼµÄ1ÐÍÅÝÄ­²¡¶¾£¨PFV-1£©¡ª¡ªÒ»ÖÖÓëÈËÌåÃâÒßȱË𲡶¾£¨HIV£©Í¬ÀàµÄÄæ×ªÂ¼Ã¸²¡¶¾¡ª¡ª×÷ΪʵÑéµÄÄ£Äâϵͳ¡£

    ÓÉÓÚP19³ÁĬ¸ÉÈÅ»ùÒòµÄ±í´ï£¬PFV-1²¡¶¾ÔÚÈ˹¤¡°ÈËÌåÅßÌ¥ÉöÔàϸ°ûÖꡱ£¨human embryonic kidney cells£©Öоۼ¯²¢ÇÒ±äµÃÊ®·ÖÃ÷ÏÔ¡£ÕâÒâζ×Å£¬ÓÉÓÚP19ϸ°û¿ØÖÆ×ÅsiRNAºÍmiRNA£¬¶øÇÒÕâÁ½ÖÖºËÌǺËËáµÄ·¾¶Ò²¿ØÖÆ×ÅPFV-1ÔÚÈËÌåϸ°ûÖеķ±Ö³¡£

    ΪÁËÈ·¶¨ÈËÌåRNA³ÁĬ»úÖÆµÄ¾ßÌå×÷Óã¬Ñо¿ÕßÃǽ«PFV-1²¡¶¾Ëùº¬ÓеIJ¡¶¾»ùÒòÐòÁÐÓëÒ»ÖÖ¸½Óб¨¸æ»ùÒòÂÌɫӫ¹âµ°°×£¨GFP£©Á´½ÓÔÚÒ»Æð£¬È»ºóʹËüÃÇÓëÈËÌåÅßÌ¥ÉöÔàϸ°ûÒ»ÆðȾÉϲ¡¶¾¡£±¨¸æÏÔʾ£¬F11¼Ü¹¹ÖеÄÂÌɫӫ¹âµ°°×ÓëF11mRNA¾Û¼¯ÖÐËùº¬ÓеÄÂÌɫӫ¹âµ°°×±ÈÀýÍêÈ«²»Í¬¡£ÕâÒ»µãʹÑо¿ÕßÃÇÏëµ½ÁËmiRNAת¼ÒÖÖÆ¡£ÀûÓÃDIANA-microTÔËËã·¨Ôò¼ÆËãºó·¢ÏÖF11ÐòÁÐÓëÈËÌåmiR-32¾ßÓи߶ȵÄÏàËÆÐÔ¡£

    ½øÒ»²½µÄÑо¿±íÃ÷£¬miR-32³ÁĬÊܵ½P19±í´ïϸ°ûµÄѹÒÖ¡£Í¬Ñù£¬ÊÜ¿¹miR-32ϸ°û¿ØÖƵĺËËáµÍ¾ÛºËÜÕËáʹ×Ó´ú²¡¶¾µÄ·±Ö³Á¿Ôö¼ÓÁËÒ»±¶£¬²¢²»ÊÇÏñ¿¹miR-32ϸ°ûËùÆðµÄ×÷ÓÃÒ»Ñù¡£ÕâÒâζ×ÅmiR-32Æð×ÅÖ±½Ó·´²¡¶¾×÷Óá£

    Ö²ÎïÓëÀ¥³æÖУ¬ËùÓеĺËÌǺËËá¸ÉÈÅ£¨RNAi£©Äܹ»ÏûÃðµÄ²¡¶¾¶¼º¬ÓпÉÒÔÒÖÖÆºËÌǺËËá³ÁĬµÄµ°°×ÖÊ¡£¶øÔÚºóÀ´µÄÑо¿½á¹ûÏÔʾ£¬PFV-1Öк¬ÓÐÒ»ÖÖ½Ð×öTasµÄ²¡¶¾·´¼¤»îµ°°×¡£

    Ò»ÖÖ½Ð×ö¡°°¢À­²®½æ¡±µÄÖ²ÎïÖУ¬×ª»ùÒòTasÄܹ»´óÁ¿¼õÉÙsiRNAs£¬²¢ÇÒʹ¸ÉÈÅ»ùÒòÒý·¢µÄϸ°û²úÉú·¢Óý±äÒìÏÖÏó£¬Í¬Ê±¸ÉÈÅmiRNAµÄ¹¦ÄÜ£¬ÀýÈçÖ²ÎïÒ¶×ӱ䳤¡¢³¤³ö¾â³ÝµÈ¡£ÕâÒâζ×ÅTas¾ßÓÐÒÖÖÆmiRNA ºÍsiRNAijÖÖ»ù±¾¹¦ÄܵÄ×÷Ó㬶øÕâÖÖ¹¦ÄÜÊÇÖ²ÎïÓ벸È鶯ÎﹲͬӵÓеġ£

    ÀàËÆTasµÄÁíÒ»ÖÖµ°°×ÖÊ£¬AC2£¬ÆäÖк¬ÓÐÖ²Îï»ùÒò²¡¶¾£¬Ò²ÊÇÒ»ÖÖ²¡¶¾·´¼¤»îµ°°×£¬Í¬ÑùÄܹ»Ñ¹ÒÖRNA³ÁĬ»úÖÆ¡£

    Ŀǰ£¬Ñо¿ÕßÃÇÈÏΪÿÖÖÀàÐ͵Äϸ°û¶¼ÓÐ×Ô¼º¶ÀÓеÄmiRNAϸ°û¿â¡£À³Î÷ÀûÑÇ˵£º¡°ÕâÑùµÄ¸ÅÄîÄܹ»²¿·Ö½â´ðһЩÓйز¡¶¾·´Ó¦·½ÃæµÄÎÊÌâ¡£¡±ËûÈÏΪ£¬ÔÚϸ°ûÖÖÀàÖУ¬ÓÅÏÈ·±Ö³µÄ²¡¶¾ÊÇ´¦ÔÚ¿¹²¡¶¾miRNAsûÓбíÏֵĵط½£¬»òÕß±íÏÖ²¢²»Ã÷ÏԵĵط½¡£

    MiRNAµÄ·´Ó¦Ò²»áµ¼Ö»ùÒò×¼ÖÖȺ³öÏÖ£¬Èç¹û²¡¶¾Äܹ»¿ìËÙʹÆä»ùÒò×é·¢Éú±äÒ죬ÀýÈçHIVÓëÁ÷¸Ð²¡¶¾£¬Ëü¾ÍÄܱÜÃâÊܵ½miRNA³ÁĬ»úÖÆµÄÓ°Ïì¡£¡°»ùÒò×¼ÖÖȺµÄ³öÏÖ¶ÔÓÚ¶ã±Ü¿¹²¡¶¾¹¦ÄܵÄÓ°ÏìÊÇÊ®·ÖÖØÒªµÄ£¬Òò´ËÑо¿ÕâÖÖmiRNA·´Ó¦Ò²Ê®·ÖÖØÒª£¬¡± À³Î÷ÀûÑÇ˵¡£

    ÕâÒ»Ñо¿Ð¡×鲢ûÓз¢ÏÖÈËÀàϸ°ûÄܹ»ÀûÓÃsiRNAÀ´ÏûÃ𲡶¾¡£¡°ËùÒÔÑо¿²¸È鶯ÎïÊÇÓû¹¾ßÓÐÀûÓÃsiRNAÀ´¶Ô¸¶²¡¶¾µÄÄÜÁ¦ÊÇÒ»¸öÊ®·ÖÓÐȤµÄ¿ÎÌ⣬ÒòΪÓëòÇò¾¡¢²ÔÓ¬ÕâЩÀ¥³æÏà±È£¬²¸È鶯ÎïÓµÓиü¼ÓÏȽøµÄÃâÒßϵͳ£¬¡±ÂéÊ¡Àí¹¤´óѧµÄ·ÉÀûÆÖ¡¤ÈüĦ˵¡£Ëû²¢Ã»ÓвμÓÕâ´ÎÑо¿»î¶¯¡£ËäÈ»miRNAsÊÇ·ñÊÇ¿¹²¡¶¾·´Ó¦µÄÔ­ÒòÖ®Ò»£¬»òÕßÖ»ÊÇżȻ¶Ô²¡¶¾ºËÌǺËËáÆðµ½Á˳ÁĬ×÷Ó㬵«ÊÇËûÈÏΪ£º¡°²»ÂÛmiRNAsµÄ±í´ïÊÇ·ñ»áÒÖÖÆ²¡¶¾´«È¾£¬ÕâÏîÑо¿¶¼»áÒýÆð¿ÆÑ§½çµÄ¹ã·º¹Ø×¢¡£¡±

    ÃÀ¹ú¼ÓÖÝ´óѧµÄ¶¡ÊØÎ¬£¨ÒôÒ룩³Æ£¬Î´À´µÄÑо¿·½Ïò¿ÉÄÜ»á°üÀ¨²âÊÔ¼¸°Ù¸öÈËÌåmicroRNAs¶ÔÖîÈçHIV²¡¶¾ºÍÁ÷¸Ð²¡¶¾µÈ²¡¶¾µÄ·´Ó¦£¬ËûҲδ²Î¼Ó´Ë´ÎÑо¿¡£Ëû˵£º¡°ËûÃÇÒѾ­ÔÚϸ°ûÅàÑøÊÒ×öÁËÊÔÑ飬Èç¹ûÔÚ¶¯ÎïÉíÉÏ×öÏà¹ØÊµÑéµÄ»°»áÒýÆð¿ÆÑ§½ç¸ü´óµÄ¹Ø×¢¡£¡±

    ·¨¹úÑо¿ÈËÔ±·¢ÏÖ£¬²¸È鶯Îïϸ°ûÄܹرÕÈëÇֵIJ¡¶¾¡£µ±²¡¶¾¸ÐȾϸ°ûºó£¬Ëü°Ñ×Ô¼ºµÄ»ùÒò²åÈëϸ°ûµÄ»ùÒò×飬ÕâÑùÔÚϸ°û¸´ÖÆÊ±Ò²²úÉúÐí¶àµÄ²¡¶¾¿½±´¡£Ñо¿ÈËÔ±ÒѾ­ÖªµÀÖ²ÎïºÍÀ¥³æÓÃRNA¸ÉÈÅʹ²¡¶¾»ùÒò³ÁĬ£¬ÔÚÕâ¸ö¹ý³ÌÖУ¬Ð¡µÄRNA·Ö×Ó½«×Ô¼º²åÈëµ½»ùÒò±í´ï»úÆ÷ÖÐʹij¸ö»ùÒò³ÁĬ¡£¶¯ÎïÒ²½«RNA¸ÉÈÅÓÃÔÚÒ»¸öµ÷½Ú¹¦ÄÜÉÏ£ºËüÃÇÔÚ·¢Óý¹ý³ÌÖÐͨ¹ýRNA¸ÉÈŸıä×Ô¼º»ùÒòµÄ±í´ï¡£Charles Henri LecellierºÍͬÊÂÏÖÔÚ·¢ÏÖ£¬ÈËÀàϸ°ûÒ²ÓÃRNA¸ÉÈÅÀ´×è°­Ò»¸öÇÖÏ®²¸ÈéÀàµÄ²¡¶¾µÄ»ýÀÛ¡£

ÒýÓÃÁ´½ÓµØÖ·£ºhttp://www.bioon.com/biology/showarticle.asp?ArticleID=102462
ÄÄÐж¼²»ºÃ¸É°¡
5Â¥2005-06-06 09:17:49
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ìì±ßµÄÒ»Æ¬ÔÆ

ľ³æ (ÕýʽдÊÖ)

invitrogen¹«Ë¾µÄRNAiר¿¯

¡ï ¡ï
miRNA(½ð±Ò+2):×ÜËã²¹³äÁË£¬Çë¼ÌÐø²¹³ä£¡£¡£¡
invitrogen¹«Ë¾µÄRNAiר¿¯
ÄÄÐж¼²»ºÃ¸É°¡
6Â¥2005-06-06 09:31:34
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ìì±ßµÄÒ»Æ¬ÔÆ

ľ³æ (ÕýʽдÊÖ)

ÖÊÁ£Îȶ¨ÐÔ²âÊÔ(Plasmid stability test)

¡ï
miRNA(½ð±Ò+1):×ÜËã²¹³äÁË£¬Çë¼ÌÐø²¹³ä£¡£¡£¡
Immediately before indcution, it is advisable to test the culture to determine the fraction of cells that still carry the target plasmid. This involves plating of cells on four different plates.

Plate cells that grow on these plate
LB plate all viable cells
LB plate + antibiotic cells that still carry the plasmid
LB plate + IPTG (1 mM) cells that have lost the plasmid or mutants that have lost the ability to express the target gene
LB plate + antibiotic + IPTG (1 mM) only mutants that retain the plasmid but have lost the ability to express the target gene

Remarks

In the presence of IPTG, cells carrying a protein production plasmid do not grow because have dedicated all their resources to the production of the recombinant protein instead of cell maintainance.
In the presence of the pLysS vector, IPTG also prevents colony formation except with certain vector (such as pET-3 and some vectors carrying the T7lac promoter). In the presence of pLysE, IPTG usually does not prevent colony formation unless the target protein is toxic.


In a typical culture useful for producing target protein, almost all cells will form colonies both on the LB plate and on the LB plate + antibiotic; less than 2% of the cells will form a colony on the LB plate + IPTG; and less than 0.01% will form a colony on the LB plate + antibiotic + IPTG.

With unstable target plasmids, the fraction of cells that have lost the plasmid will be reflected by an increase in colonies on the LB plate + IPTG and a decrease on ther LB plate + antibiotic.




Protocol

1. Immediately before induction with IPTG (at OD600 is approx. 0.6), take a 100-ml aliquot of the cell culture.
2. Make a serial dilution of the cell suspension, including a 105 and 106 dilution.
3. Plate cells at a dilution of 105 on the LB plate + IPTG and on the LB plate + IPTG + antibiotic.

Plate cells at a dilution of 106 on the LB plate and on the LB plate + antibiotic.
4. Incubate the plates overnight a 37¡ãC.
5. Count the number of colonies on each plate.


Reference: pET System Manual, 8th ed., 1999 (Novagen).
ÄÄÐж¼²»ºÃ¸É°¡
7Â¥2005-06-06 09:37:04
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ìì±ßµÄÒ»Æ¬ÔÆ

ľ³æ (ÕýʽдÊÖ)

¶¨ Á¿ P C R

¡ï ¡ï
miRNA(½ð±Ò+2):ºÃ¶àѽ£¬Ï´ηŵ½¼Çʱ¾À£¡£¡
¶¨Á¿PCR
ÒÔ²ÎÕÕÎïΪ±ê×¼¶ÔPCRÖÕ²úÎï½øÐзÖÎö»ò¶ÔPCR¹ý³ÌµÄ½øÐмà²â£¬À´ÆÀ¹ÀÑù±¾ÖалùÒòµÄ¿½±´Êý£¬³ÆÎª¶¨Á¿PCR¡£

[ Last edited by Ìì±ßµÄÒ»Æ¬ÔÆ on 2005-6-6 at 20:48 ]
ÄÄÐж¼²»ºÃ¸É°¡
8Â¥2005-06-06 20:08:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

aqi96

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

ÕâÑùµÄ×ÊÁϳä³âÓÚÍøÂç¼ä£¬Ò²ÊÇÎåÐǼ¶½±Àø£¿Ì¾£¡
×ö×îºÃµÄ×Ô¼º
9Â¥2005-06-06 20:30:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ìì±ßµÄÒ»Æ¬ÔÆ

ľ³æ (ÕýʽдÊÖ)

PCR mutation detection protocols

4.PCR mutation detection protocols
ÄÄÐж¼²»ºÃ¸É°¡
10Â¥2005-06-06 20:48:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Ìì±ßµÄÒ»Æ¬ÔÆ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 284Çóµ÷¼Á +5 Zhao anqi 2026-03-22 5/250 2026-03-22 17:38 by barlinike
[¿¼ÑÐ] ÉúÎïѧ071000 329·ÖÇóµ÷¼Á +5 ÎÒ°®ÉúÎïÉúÎﰮΠ2026-03-17 5/250 2026-03-22 16:42 by tcx007
[¿¼ÑÐ] 298Çóµ÷¼ÁÒ»Ö¾Ô¸211 +3 Éϰ¶6666@ 2026-03-20 3/150 2026-03-22 15:50 by ColorlessPI
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ 070300 ѧ˶ 336·Ö Çóµ÷¼Á +3 vvÃÔ 2026-03-22 3/150 2026-03-22 15:18 by ÑîÑîÑî×Ï
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤085600£¬×Ü·Ö304£¬±¾¿ÆÓÐÁ½Æªsci²ÎÓ룬Çóµ÷¼Á +3 ÐÒÔ˵Ľ´½´ 2026-03-22 4/200 2026-03-22 15:06 by allen-yin
[¿¼ÑÐ] 269ר˶Çóµ÷¼Á +6 ½ð¶÷±´ 2026-03-21 6/300 2026-03-22 14:31 by ColorlessPI
[¿¼ÑÐ] ²ÄÁÏѧ˶301·ÖÇóµ÷¼Á +7 Liyouyumairs 2026-03-21 7/350 2026-03-21 22:31 by peike
[¿¼ÑÐ] 0805 316Çóµ÷¼Á +3 ´óÑ©Éî²Ø 2026-03-18 3/150 2026-03-21 18:55 by ѧԱ8dgXkO
[¿¼ÑÐ] ¡¾¿¼Ñе÷¼Á¡¿»¯Ñ§×¨Òµ 281·Ö£¬Ò»Ö¾Ô¸ËÄ´¨´óѧ£¬³ÏÐÄÇóµ÷¼Á +11 ³Ô³Ô³Ô²ÅÓÐÒâÒå 2026-03-19 11/550 2026-03-21 18:23 by ѧԱ8dgXkO
[¿¼ÑÐ] 316Çóµ÷¼Á +6 ÁºÜçö© 2026-03-19 6/300 2026-03-21 06:32 by Ecowxq666£¡
[¿¼ÑÐ] 299Çóµ÷¼Á +6 ¡÷С͸Ã÷* 2026-03-17 6/300 2026-03-21 02:42 by JourneyLucky
[¿¼ÑÐ] 274Çóµ÷¼Á +10 S.H1 2026-03-18 10/500 2026-03-20 23:51 by JourneyLucky
[¿¼ÑÐ] ҩѧ383 Çóµ÷¼Á +3 ҩѧchy 2026-03-15 5/250 2026-03-20 22:11 by ÔÆÓÎÖØÑô
[¿¼ÑÐ] Ò»Ö¾Ô¸ËÕÖÝ´óѧ²ÄÁÏÇóµ÷¼Á£¬×Ü·Ö315£¨Ó¢Ò»£© +5 sbdksD 2026-03-19 5/250 2026-03-20 22:10 by luoyongfeng
[¿¼ÑÐ] Çóµ÷¼ÁÒ»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ289·Ö +3 @taotao 2026-03-19 3/150 2026-03-20 21:34 by JourneyLucky
[¿¼ÑÐ] Çóµ÷¼Á +3 eation27 2026-03-20 3/150 2026-03-20 19:32 by JourneyLucky
[¿¼ÑÐ] Çóµ÷¼Á +3 °µÓ¿afhb 2026-03-16 3/150 2026-03-20 00:28 by ºÓÄÏ´óѧУÓÑ
[¿¼ÑÐ] 085601ר˶£¬×Ü·Ö342Çóµ÷¼Á£¬µØÇø²»ÏÞ +5 share_joy 2026-03-16 5/250 2026-03-18 14:48 by haxia
[¿¼ÑÐ] 308Çóµ÷¼Á +4 ÊÇLupa°¡ 2026-03-16 4/200 2026-03-17 17:12 by ruiyingmiao
[¿¼ÑÐ] [µ¼Ê¦ÍƼö]Î÷ÄϿƼ¼´óѧ¹ú·À/²ÄÁϵ¼Ê¦ÍƼö +3 ¼â½ÇСºÉ 2026-03-16 6/300 2026-03-16 23:21 by ¼â½ÇСºÉ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û